13C/31P MRS Metabolic Biomarkers of Disease Progression and Response to AAV Delivery of hGAA in a Mouse Model of Pompe Disease

13C/31P MRS Metabolic Biomarkers of Disease Progression and Response to AAV Delivery of hGAA in a Mouse Model of Pompe Disease

The development of therapeutic clinical trials for glycogen storage disorders, including Pompe disease, has called for non-invasive and objective biomarkers. Glycogen accumulation can be measured in vivo with 13C MRS. However, clinical implementation remains challenging due to low signal-to-noise. O...

Full description

Bibliographic Details
Main Authors:	Celine Baligand, Adrian G. Todd, Brittany Lee-McMullen, Ravneet S. Vohra, Barry J. Byrne, Darin J. Falk, Glenn A. Walter
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Series:	Molecular Therapy: Methods & Clinical Development
Subjects:	gene therapy MR spectroscopy Pompe disease glycogen storage disorder MRI AAV glucose-6-phosphate glycogen carbon phosphorus
Online Access:	http://www.sciencedirect.com/science/article/pii/S2329050117300992

Similar Items

Hypoglossal neuropathology and respiratory activity in Pompe mice
by: Kun-Ze eLee, et al.
Published: (2011-06-01)

Homozygotic intronic GAA mutation in three siblings with late-onset Pompe's disease Mutação homozigótica intrônica no gene GAA em três irmãos com doença de Pompe de início tardio
by: Anderson Kuntz Grzesiuk, et al.
Published: (2010-04-01)

Skeletal muscle metabolism during prolonged exercise in Pompe disease
by: Nicolai Preisler, et al.
Published: (2017-07-01)

Late-Onset Pompe Disease: A Diagnostic Challenge
by: Ritesh Shah, et al.
Published: (2021-04-01)

Hypothyroidism in late-onset Pompe disease
by: Joseph Schneider, et al.
Published: (2016-09-01)

Calf muscle hypertrophy in late onset pompe's disease
by: M Suraj Menon, et al.
Published: (2016-01-01)

Novel GAA Variants and Mosaicism in Pompe Disease Identified by Extended Analyses of Patients with an Incomplete DNA Diagnosis
by: Stijn L.M. in ’t Groen, et al.
Published: (2020-06-01)

Pompe disease, a storage cardiomyopathy
by: Tiziana Felice
Published: (2017-10-01)

Experience with the Urinary Tetrasaccharide Metabolite for Pompe Disease in the Diagnostic Laboratory
by: Jennifer T. Saville, et al.
Published: (2021-07-01)

Moss-Derived Human Recombinant GAA Provides an Optimized Enzyme Uptake in Differentiated Human Muscle Cells of Pompe Disease
by: Stefan Hintze, et al.
Published: (2020-04-01)

Current pharmacotherapy and diagnostic methods of Pompe Disease in Poland
by: Dominika Anna Janeczko, et al.
Published: (2019-09-01)

A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme
by: Jeong-A Lim, et al.
Published: (2020-09-01)

Comparisons of Infant and Adult Mice Reveal Age Effects for Liver Depot Gene Therapy in Pompe Disease
by: Sang-oh Han, et al.
Published: (2020-06-01)

Reporting 7 Pompe Patients in Iran
by: Milad Ebrahimi, et al.
Published: (2017-05-01)

Anaesthetic management of a patient with Pompe disease for kyphoscoliosis correction
by: Vaishali Kumbar, et al.
Published: (2016-01-01)

Molecular basis and clinical management of Pompe disease
by: Giancarlo Parenti, et al.
Published: (2013-02-01)

Pregnancy Outcomes in Late Onset Pompe Disease
by: Ozlem Goker-Alpan, et al.
Published: (2020-09-01)

The effects of laforin, malin, Stbd1, and Ptg deficiencies on heart glycogen levels in Pompe disease mouse models
by: Conway, Betsy Ann
Published: (2016)

Biomarkers in Glycogen Storage Diseases: An Update
by: Alberto Molares-Vila, et al.
Published: (2021-04-01)

Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report
by: Zhang B, et al.
Published: (2016-03-01)

Medical image of the month: late-onset Pompe disease
by: Hernandez Z,, et al.
Published: (2020-03-01)

Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand
by: Lukana Ngiwsara, et al.
Published: (2019-09-01)

Pompe Disease: Early Diagnosis and Early Treatment Make a Difference
by: Yin-Hsiu Chien, et al.
Published: (2013-08-01)

Analysis of Parental Perception of Swallowing and Voice in Infants and Children with Pompe Disease
by: Cecchi, Alana
Published: (2011)

Uptake of moss‐derived human recombinant GAA in Gaa−/− mice
by: Stefan Hintze, et al.
Published: (2021-05-01)

A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations
by: Herzog Andreas, et al.
Published: (2012-06-01)

The Release of a Soluble Glycosylated Protein from Glycogen by Recombinant Lysosomal α-Glucosidase (rhGAA) In Vitro and Its Presence in Serum In Vivo
by: Allen K. Murray
Published: (2020-11-01)

New Insights into Gastrointestinal Involvement in Late-Onset Pompe Disease: Lessons Learned from Bench and Bedside
by: Aditi Korlimarla, et al.
Published: (2021-07-01)

Correlation Between Respiratory Accessory Muscles and Diaphragm Pillars MRI and Pulmonary Function Test in Late-Onset Pompe Disease Patients
by: David Reyes-Leiva, et al.
Published: (2021-03-01)

Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
by: Chien-Yu Hsueh, et al.
Published: (2021-08-01)

Infantile-onset Pompe disease (the first case diagnosed in Voronezh)
by: V. P. Fedotov, et al.
Published: (2015-02-01)

Aspectos respiratórios da doença de Pompe: Relato de caso Respiratory aspects of Pompe disease: Case report
by: Ewandro LR Moura, et al.
Published: (2008-02-01)

Assessment of adeno-associated virus gene therapies efficacy on acid alpha-glucosidase restoration and glycogen storage correction in cardiac muscle of Pompe disease mice using synchrotron infrared and ultraviolet microspectroscopies
by: Laurence Dubreil, et al.
Published: (2019-08-01)

Characteristics of Pompe disease in China: a report from the Pompe registry
by: Yuying Zhao, et al.
Published: (2019-04-01)

Glycogen metabolism in Lafora disease
by: Contreras, Christopher J.
Published: (2018)

Molecular and clinical characterization of Colombian patients suffering from type III glycogen storage disease
by: Carolina Mantilla, et al.
Published: (2018-05-01)

Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients
by: J. J. A. van den Dorpel, et al.
Published: (2020-09-01)

‘Double-trouble’ for respiratory control in Pompe disease
by: Ken D. O’Halloran
Published: (2011-09-01)

Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy
by: Reuser Arnold JJ, et al.
Published: (2011-06-01)

De Novo Glycogen Biosynthesis by a Glycogen Primer Complex in the Obliquely Striated Skeletal Muscle of Ascaris suum
by: Ghosh, Paritosh
Published: (1987)